$WW·8-K

WW INTERNATIONAL, INC. · Apr 3, 2:11 PM ET

Compare

WW INTERNATIONAL, INC. 8-K

Research Summary

AI-generated summary

Updated

WW International CEO Resigns; Interim Co‑CEOs Named

What Happened

  • WW International (WW) filed an 8-K reporting that President and CEO Tara Comonte resigned effective March 31, 2026. The Board accepted her resignation and she also stepped down from the Board.
  • Effective April 3, 2026, the company established an Interim Office of the Chief Executive Officer (OCEO) comprised of CFO Felicia DellaFortuna (age 42) and COO Jonathan Volkmann (age 39) to serve as the company’s principal executive officers until a permanent CEO is appointed.
  • Chief Legal & Administrative Officer and Secretary Jaqueline Cooke resigned at the Board’s request, effective April 10, 2026; Debra Cotter was appointed Chief Legal Officer and Secretary effective upon Cooke’s departure.
  • Two directors, Julie Bornstein and Fallon O’Connor, resigned effective April 1, 2026; the Board size was reduced from seven to four.

Key Details

  • CEO resignation effective: March 31, 2026. Interim OCEO effective: April 3, 2026. Director resignations effective: April 1, 2026. CLO transition effective: April 10, 2026.
  • Separation package for outgoing CLO Jaqueline Cooke: $1,500,000 in cash (two equal installments), employer-paid portion of health premiums for up to 36 months (or until eligible for other coverage), and reimbursement of attorneys’ fees of $107,480; equity and cash awards under the company plan were forfeited as of the separation date.
  • Bylaws amended April 3, 2026 to change authorized Board size to between 3 and 15 directors (previously 5 to 15), with the exact number set by Board resolution.

Why It Matters

  • Leadership and governance change: the sudden CEO exit, the interim co‑leadership by the CFO and COO, and the resignations of two directors materially alter WW’s senior management and Board composition—items investors typically watch closely for potential strategic and operational impacts.
  • Financial and governance implications: the company will incur a known cash cost tied to the CLO separation ($1.5M plus $107.5K in legal fees and continuation of health premiums), and the bylaws change gives the Board flexibility to operate with a smaller board while it searches for permanent replacements.
  • Next steps for investors: monitor company communications and filings for appointment of a permanent CEO, any additional Board nominations, and updates on strategy or guidance tied to the leadership transition.